ADMA Biologics (ADMA) had the highest return between 2022 and 2024 by a mid-cap US stock, returning 1,125%.

ASSET	YEARS	% RETURN
ADMA Biologics (ADMA)	2022-2024	1,125%
Modine Manufacturing (MOD)	2022-2024	1,033.24%
Sezzle (SEZL)	2022-2024	1,029.36%
Vista Oil Gas ADR (VIST)	2022-2024	920.94%
Banco Macro SA B ADR (BMA)	2022-2024	804.54%
Viking Therapeutics (VKTX)	2022-2024	761.67%
BBVA Banco Frances SA ADR (BBAR)	2022-2024	708.84%
Powell Industries (POWL)	2022-2024	701.06%
Grupo Financiero Galicia SA ADR (GGAL)	2022-2024	696.49%
Applied Opt (AAOI)	2022-2024	608.85%
Soleno Therapeutics (SLNO)	2022-2024	605.1%
Transportadora de Gas del Sur SA ADR (TGS)	2022-2024	554.81%
Bel Fuse B (BELFB)	2022-2024	550.25%
Sterling Construction (STRL)	2022-2024	534.46%
Bel Fuse A (BELFA)	2022-2024	512.67%
Central Puerto (CEPU)	2022-2024	461.19%
Rhythm Pharmaceuticals (RYTM)	2022-2024	459.8%
United States Lime & Minerals (USLM)	2022-2024	415.05%
Tidewater (TDW)	2022-2024	411.31%
Belite Bio Inc ADR (BLTE)	2022-2024	404.8%
Solaris Energy Infrastructure (SEI)	2022-2024	397.23%
Quantum Computing (QUBT)	2022-2024	375.57%
F&G Annuities & Life (FG)	2022-2024	336.6%
Sprouts Farmers Market LLC (SFM)	2022-2024	328.13%
Abercrombie & Fitch (ANF)	2022-2024	324.63%

Mid-cap stocks are treated as having a market cap between $2B and $10B.